These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 28926106

  • 21. Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells.
    Tong Q, Zhao Q, Qing Y, Hu X, Jiang L, Wu X.
    Steroids; 2015 Apr; 96():30-6. PubMed ID: 25554580
    [Abstract] [Full Text] [Related]

  • 22. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.
    PLoS One; 2012 Apr; 7(12):e52279. PubMed ID: 23300633
    [Abstract] [Full Text] [Related]

  • 23. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway.
    Weng WT, Huang SC, Ma YL, Chan HH, Lin SW, Wu JC, Wu CY, Wen ZH, Wang EM, Wu CL, Tai MH.
    Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634
    [Abstract] [Full Text] [Related]

  • 24. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
    Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS.
    J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
    [Abstract] [Full Text] [Related]

  • 25. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, Li L, Tang B, Allen TD, Liu J.
    Cancer Biol Ther; 2014 Mar; 15(11):1479-88. PubMed ID: 25482945
    [Abstract] [Full Text] [Related]

  • 26. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X, Yue GG, Liu M, Zuo Z, Lee JK, Li M, Tsui SK, Fung KP, Sun H, Pu J, Lau CB.
    Oncotarget; 2016 Dec 13; 7(50):82820-82835. PubMed ID: 27756875
    [Abstract] [Full Text] [Related]

  • 27. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA, Arafa el-SA, Salama SA, Arab HH, Wu CH, Weng JR.
    Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):616-24. PubMed ID: 23921148
    [Abstract] [Full Text] [Related]

  • 28. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
    Li B, Zhang Y, Yin R, Zhong W, Chen R, Yan J.
    Mediators Inflamm; 2020 Nov 01; 2020():1649453. PubMed ID: 33162828
    [Abstract] [Full Text] [Related]

  • 29. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
    Mu X, Shi W, Sun L, Li H, Jiang Z, Zhang L.
    Molecules; 2012 Jun 05; 17(6):6854-68. PubMed ID: 22669041
    [Abstract] [Full Text] [Related]

  • 30. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A, Sunita P, Jha S, Pattanayak SP.
    Clin Exp Pharmacol Physiol; 2016 Oct 05; 43(10):939-50. PubMed ID: 27297262
    [Abstract] [Full Text] [Related]

  • 31. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J, Kaushik S, Rath SK, Balapure AK.
    Life Sci; 2018 Jan 15; 193():9-19. PubMed ID: 29196053
    [Abstract] [Full Text] [Related]

  • 32. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
    Wan L, Zhao Y, Zhang Q, Gao G, Zhang S, Gao Y, Chen X, Qian X.
    BMC Complement Altern Med; 2019 Dec 10; 19(1):359. PubMed ID: 31823762
    [Abstract] [Full Text] [Related]

  • 33. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
    Zhang Y, Hu G, Li S, Li ZH, Lam CO, Hong SJ, Kwan YW, Chan SW, Leung GP, Lee SM.
    Mol Med Rep; 2012 Mar 10; 5(3):805-11. PubMed ID: 22179585
    [Abstract] [Full Text] [Related]

  • 34. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM, Mc Entire J, Pallini R, Vakana E, Wyss L, Blosser W, Ricci-Vitiani L, D'Alessandris QG, Morgante L, Giannetti S, Larocca LM, Todaro M, Benfante A, Colorito ML, Stassi G, De Maria R, Rowlinson S, Stancato L.
    PLoS One; 2015 Mar 10; 10(4):e0125697. PubMed ID: 25919028
    [Abstract] [Full Text] [Related]

  • 35. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Oncotarget; 2016 Sep 27; 7(39):63124-63137. PubMed ID: 27517319
    [Abstract] [Full Text] [Related]

  • 36. Oroxyloside inhibits human glioma progression by suppressing proliferation, metastasis and inducing apoptosis related pathways.
    Xu ZF, Sun XK, Chen G, Han C, Wang F, Zhang YD.
    Biomed Pharmacother; 2018 Jan 27; 97():1564-1574. PubMed ID: 29793319
    [Abstract] [Full Text] [Related]

  • 37. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Li T, Liu X, Shen Q, Yang W, Huo Z, Liu Q, Jiao H, Chen J.
    Oncotarget; 2016 May 03; 7(18):26580-92. PubMed ID: 27058891
    [Abstract] [Full Text] [Related]

  • 38. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC, Yang CM, Song TY, Yang NC, Hu ML.
    Life Sci; 2015 Oct 15; 139():52-61. PubMed ID: 26285173
    [Abstract] [Full Text] [Related]

  • 39. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
    Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, Yang DP, Chen YL, Shen JG, Chen JP.
    Breast Cancer Res Treat; 2012 Aug 15; 134(3):943-55. PubMed ID: 22350787
    [Abstract] [Full Text] [Related]

  • 40. Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo.
    Shukla K, Sonowal H, Saxena A, Ramana KV.
    Vascul Pharmacol; 2019 Apr 15; 115():18-25. PubMed ID: 30634049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.